质母细胞瘤治疗:过去,现在和未来
Elena Obrador1,2, Paz Moreno-Murciano1, María Oriol-Caballo1,2
1Scientia BioTech S.L., 46002 Valencia, Spain.
International journal of molecular sciences
|March 13, 2024
概括
质母细胞瘤治疗仍然具有挑战性,生存率的改善有限. 本综述探讨了最近在理解质瘤干细胞,瘤微环境和表观遗传学方面的进展,以及新的治疗策略,如免疫疗法和纳米疗法.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 质母细胞瘤 (GB) 是最常见和最致命的脑癌,其生存率自2005年以来基本没有变化.
- 尽管目前的标准护理 (SOC) 治疗方法,但复发几乎是普遍的,这凸显了改善治疗策略的迫切需要.
研究的目的:
- 审查了解质母细胞瘤病理生理学的最新进展,重点关注质母细胞 (GSC),瘤微环境和表观遗传机制.
- 分析目前和新兴的质母细胞瘤治疗策略,包括向疗法,免疫疗法,纳米疗法和基于非电离能量的治疗方法.
主要方法:
- 关于质母细胞瘤 (GB) 病理生理学和治疗干预措施的最新研究的文献综述.
- 讨论标准护理 (SOC) 治疗,向疗法,免疫疗法,纳米疗法以及基于非电离能量的方法.
主要成果:
- 质母细胞瘤的生长,攻击性和复发受到质母细胞 (GSC),瘤微环境和表观遗传因素的影响.
- 向疗法,免疫疗法,纳米疗法和非电离能源模式显示出希望,但面临着与有效性和耐药性相关的挑战.
结论:
- 更深入地了解GB病理生理学对于开发有效的治疗方法至关重要.
- 新型治疗方法,包括免疫疗法和纳米疗法,有可能改善患者的治疗结果,并需要进一步的临床研究.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


